Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19

Xabier García-Albéniz, Julia del Amo, Rosa Polo, José Miguel Morales-Asencio, Miguel A Hernán
doi: https://doi.org/10.1101/2020.09.29.20203869
Xabier García-Albéniz
1RTI Health Solutions. Barcelona, Spain
2Department of Epidemiology. Harvard T.H. Chan School of Public Health. Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xgarcia{at}rti.org
Julia del Amo
3National Plan Against AIDS, Ministry of Health. Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Polo
3National Plan Against AIDS, Ministry of Health. Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Miguel Morales-Asencio
4Department of Nursing and Podiatry, Universidad de Málaga, Málaga, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel A Hernán
2Department of Epidemiology. Harvard T.H. Chan School of Public Health. Boston, MA, USA
5Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Recruitment into randomized trials of hydroxychloroquine (HCQ) for prevention of COVID-19 is being threatened by a widespread conviction that HCQ is not effective for prevention. In the absence of an updated systematic review, we conducted a meta-analysis of randomized trials that study the effectiveness of HCQ to prevent COVID-19.

Methods and Findings A search of PubMed, Embase, and medRxiv with expert consultation found four completed randomized trials: two pre-exposure prophylaxis trials and two post-exposure prophylaxis trials. We obtained or calculated the risk ratio of COVID-19 diagnosis for assignment to HCQ versus no HCQ (either placebo or usual care) for each trial, and then pooled the risk ratio estimates. The risk ratio estimated for each of the individual trials were 0.74 (95% CI 0.50-1.10), 0.95 (0.25, 3.64), 0.83 (95% CI: 0.58-1.18), and 0.69 (95% CI: 0.35-1.37). The pooled risk ratio estimate was 0.78 (95% CI: 0.61-0.99) when using either a fixed effect or a standard random effects approach, and 0.78 (95% CI: 0.53-1.16) when using a conservative modification of the Hartung-Knapp random effects approach. All four trials found a similar rate of serious adverse effects in the HCQ and no HCQ groups.

Discussion A pooled analysis of these randomized trials cannot rule out a moderate reduction of COVID-19 risk after assignment to HCQ. Yet the findings from the randomized trials were widely interpreted as definite evidence of lack of effectiveness of HCQ, simply because they were not “statistically significant”. Completion of the ongoing trials is needed to generate more precise estimates of the effectiveness of HCQ to prevent COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was not funded

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • An additional clinical trial was added to the meta-analysis

Data Availability

Data used in the analysis are publicly available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Xabier García-Albéniz, Julia del Amo, Rosa Polo, José Miguel Morales-Asencio, Miguel A Hernán
medRxiv 2020.09.29.20203869; doi: https://doi.org/10.1101/2020.09.29.20203869
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Xabier García-Albéniz, Julia del Amo, Rosa Polo, José Miguel Morales-Asencio, Miguel A Hernán
medRxiv 2020.09.29.20203869; doi: https://doi.org/10.1101/2020.09.29.20203869

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13384)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14637)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)